ASME Congressional Briefing
Bioengineering: A New Frontier in American Manufacturing
Date: Thursday, June 14, 2018
Location: Senate Dirksen 106 (The Rules Committee Hearing Room)
Lunch will be provided.
Dean Kamen , Executive Director, ARMI & BioFabUSA, a Manufacturing USA Institute focused on large-scale manufacturing and commercialization of engineered tissues
Michael Golway, President and CEO, Advanced Solutions, makers of the BioAssemblyBot™ multi-axis robot that 3D prints living tissue
Jennifer Hagan-Dier, Director, Tennessee NIST Manufacturing Extension Partnership (TMEP), delivering consulting and training services to medium- and small-sized manufacturers
The American Society of Mechanical Engineers (ASME) is hosting a Congressional Briefing to highlight efforts aimed to advance biomanufacturing technology here in the U.S. and to share what can be done to promote American technological leadership in this new, quickly-progressing field of engineering. Biomanufacturing will transform our health industry and change the way we care for our veterans. From grafting new skin to 3D-printing biomaterials that will create bones and organs, the advances made today will have profound impact for patients of all kinds. Global competition to develop these new technologies is fierce, and as our engineers, doctors, and scientists continue to innovate, they government plays an integral role in ensuring this technology is invented and applied here in the U.S. From cultivating the brightest minds at our universities and labs, to training and building a technical workforce, the challenges facing biomanufacturing span industries and, or our solutions must as well.
This is a widely attended public event.